Zobrazeno 1 - 8
of 8
pro vyhledávání: '"LIU Hong⁃xian"'
Clinical symptoms and molecular biology research in a family with oculopharyngeal muscular dystrophy
Publikováno v:
Chinese Journal of Contemporary Neurology and Neurosurgery, Vol 21, Iss 06, Pp 460-465 (2021)
Objective To investigate the clinical symptoms and molecular biological characteristics in a family with oculopharyngeal muscular dystrophy (OPMD). Methods Clinical data of the family members were collected. Genomic DNA were isolated from peripheral
Externí odkaz:
https://doaj.org/article/cbe2ce3e07034367b2d403daf8a290f1
Autor:
LIU Hong-xian, YANG Jun
Publikováno v:
Jichu yixue yu linchuang, Vol 41, Iss 5, Pp 623-629 (2021)
Objective To investigate the role of inhibitor of DNA binding-2 (ID2) in pulmonary vasculature formation in early lung development. Methods CRISPR/Cas9 system was used to edit ID2 in human embryonic stem cells (hESCs) to construct ID2 knockout strain
Externí odkaz:
https://doaj.org/article/5d3ce9eec30e43b18bae0f548f9cb0bf
Autor:
Wan, Tao1, Liu, Hong-Xian1
Publikováno v:
Petroleum Science (Springer Nature). Aug2018, Vol. 15 Issue 3, p552-563. 12p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Liu, Hong Xian, Li, Bin Xia
Publikováno v:
Applied Mechanics and Materials; July 2014, Vol. 597 Issue: 1 p484-487, 4p
Publikováno v:
Advanced Materials Research; September 2013, Vol. 773 Issue: 1 p628-633, 6p
Autor:
Zhang LY; Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Yu JY; Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Leng YL; Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Zhu RR; Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Liu HX; Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Wang XY; Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Yang TT; Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Guo YN; Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Tang JL; Department of Pharmaceutics, School of Pharmacy, Harbin Medical University, Harbin, Heilongjiang Province, China. 101133@hrbmu.edu.cn., Zhang XC; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China. xczhang1973@hrbmu.edu.cn.
Publikováno v:
Cancer gene therapy [Cancer Gene Ther] 2022 Jun; Vol. 29 (6), pp. 770-783. Date of Electronic Publication: 2021 Jun 18.